Clinical trials
Phase 2 Myelodysplastic Syndromes trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 4 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| St. Petersburg State Pavlov Medical University | 7 |
| Janssen Research & Development, LLC | 3 |
| Novartis Pharmaceuticals | 3 |
| Celgene Corporation | 1 |
| Ivan S Moiseev | 1 |
| Universitätsklinikum Hamburg-Eppendorf | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 16 |
| Leukemia, Myeloid, Acute | 9 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 |
| Myeloproliferative Disorders | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Leukemia, Biphenotypic, Acute | 3 |
| Graft vs Host Disease | 2 |
| Immune System Diseases | 2 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2 |
| Iron Overload | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.